News

The next EUFEPS Talks will take place on September 28, 2026 from 4 pm – 5 pm CEST. Michael Rühl will give a talk with the title: "Where Research Meets Manufacturing: Analytical Innovation for Therapeutic Oligonucleotides.

The Finnish Pharmaceutical Society is excited to organize the 2nd pitching competition for PhD students as part of FinPharmSci 2026 event. This year, we will select two winners:
One to represent Finland in the European PhD pitching competition at the EUFEPS Annual Meeting 2027, in Krakow, May 19-21, 2027, and one to represent Finland in the Young Scientist Symposium to be held in the context of the EFMC Synthetic and Medicinal Chemistry Meeting 2027, in Edinburgh, September 3-4, 2027 – with a possibility for oral presentation at the Symposium (speakers to be selected from among national representatives by the EFMC’s Young Scientist Network).

The Finnish Pharmaceutical Society is pleased to announce the call for nominations for the “Most Outstanding Pharmaceutical Research Article” award. This award provides an opportunity for researchers to be recognized and honored for their valuable contributions to pharmaceutical sciences. The award is 500€, and the winner will be announced at the FinPharmSci 2026 event in November. Please send your nomination to arto.merivaara@uef.fi by September 30, 2026.

The Finnish Pharmaceutical Society is delighted to announce the call for nominations for the prestigious Albert Wuokko Award for the best doctoral thesis. This biennial award, valued at 4000 euros, is the highest recognition in the pharmaceutical field in Finland and provides a fantastic opportunity for newly graduated PhDs to gain recognition and honor for their outstanding contributions to pharmaceutical sciences. Applications should be submitted to arto.merivaara@uef.fi by July 31st, 2026.

The annual meeting of the society was held last Tuesday in Helsinki.

The grant application period is 1.5.-31.5.2026, and during the application period, personal grants can be applied for doctoral studies aiming at a PhD degree. Grants will not be awarded for postdoctoral research. The grant decisions are made by the board of the Finnish Pharmaceutical Society, and the grant recipients will be notified by the latest at the beginning of September. The grant period may begin at the end of 2026 or in 2027, but the grant must be used in full by the end of  2027.

The Finnish Pharmaceutical Society is pleased to share information about the upcoming conference “Computational and Medicinal Chemistry by the Lake 2026,” taking place in Kuopio, Finland, on 2–4 June 2026. Registration is now open!

The Finnish Pharmaceutical Society is pleased to announce the opening of the call for applications for travel grants and grants for organizing scientific meetings or conferences.
The application time for the grants is 1.1.-31.1.2026. Grants can be applied for (1) personal participation in scientific meetings and events, and (2) organizing a scientific meeting or conference. The travel grants (1) are primarily intended to support doctoral candidates conducting PhD studies.

The FinPharmSci 2025 event was held on Thursday, November 6, featuring excellent pitching presentations by PhD students, engaging research talks by grant recipients, and an inspiring keynote by the 2025 Albert Wuokko Award winner. During the event, the winners of the article award, honorary mentions, and master of pharmacy awards were also announced. Congratulations to all awardees, and thank you to everyone who participated!

The Finnish Pharmaceutical Society is pleased to announce the call for nominations for the “Most Outstanding Pharmaceutical Research Article” award. This award provides an opportunity for researchers to be recognized and honored for their valuable contributions to pharmaceutical sciences. The award is 500€, and the winner will be announced at the FinPharmSci 2025 event in November. Please send your nomination to arto.merivaara@uef.fi by September 26, 2025.